BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Silveira MG, Lindor KD. Clinical features and management of primary sclerosing cholangitis. World J Gastroenterol 2008; 14(21): 3338-3349 [PMID: 18528931 DOI: 10.3748/wjg.14.3338] [Cited by in CrossRef: 40] [Cited by in F6Publishing: 27] [Article Influence: 2.9] [Reference Citation Analysis]
Number Citing Articles
1 Zampetti A, Rinninella E, Manna R, Franceschi F. Scleroderma and liver disease: a case of an association with primary sclerosing cholangitis. Scand J Rheumatol 2016;45:334-5. [PMID: 26690847 DOI: 10.3109/03009742.2015.1114667] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
2 Tringali A, Bove V, Costamagna G. Endoscopic approach to benign biliary obstruction. Gastrointestinal Intervention 2015;4:1-8. [DOI: 10.1016/j.gii.2015.04.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
3 Rossi RE, Conte D, Massironi S. Primary sclerosing cholangitis associated with inflammatory bowel disease: an update. European Journal of Gastroenterology & Hepatology 2016;28:123-31. [DOI: 10.1097/meg.0000000000000532] [Cited by in Crossref: 32] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
4 de Chambrun GP, Nachury M, Funakoshi N, Gerard R, Bismuth M, Valats JC, Panaro F, Navarro F, Desreumaux P, Pariente B, Blanc P. Oral vancomycin induces sustained deep remission in adult patients with ulcerative colitis and primary sclerosing cholangitis. Eur J Gastroenterol Hepatol. 2018;30:1247-1252. [PMID: 30052539 DOI: 10.1097/meg.0000000000001223] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
5 Kornbluth A, Sachar DB;  Practice Parameters Committee of the American College of Gastroenterology. Ulcerative colitis practice guidelines in adults: American College Of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol. 2010;105:501-23; quiz 524. [PMID: 20068560 DOI: 10.1038/ajg.2009.727] [Cited by in Crossref: 826] [Cited by in F6Publishing: 730] [Article Influence: 68.8] [Reference Citation Analysis]
6 Trottier J, Białek A, Caron P, Straka RJ, Heathcote J, Milkiewicz P, Barbier O. Metabolomic profiling of 17 bile acids in serum from patients with primary biliary cirrhosis and primary sclerosing cholangitis: a pilot study. Dig Liver Dis 2012;44:303-10. [PMID: 22169272 DOI: 10.1016/j.dld.2011.10.025] [Cited by in Crossref: 78] [Cited by in F6Publishing: 77] [Article Influence: 7.1] [Reference Citation Analysis]
7 Mackay IR. Clustering and commonalities among autoimmune diseases. Journal of Autoimmunity 2009;33:170-7. [DOI: 10.1016/j.jaut.2009.09.006] [Cited by in Crossref: 71] [Cited by in F6Publishing: 63] [Article Influence: 5.5] [Reference Citation Analysis]
8 Sinakos E, Samuel S, Enders F, Loftus EV, Sandborn WJ, Lindor KD. Inflammatory bowel disease in primary sclerosing cholangitis: a robust yet changing relationship. Inflamm Bowel Dis. 2013;19:1004-1009. [PMID: 23502353 DOI: 10.1097/mib.0b013e3182802893] [Cited by in Crossref: 33] [Cited by in F6Publishing: 16] [Article Influence: 3.7] [Reference Citation Analysis]
9 Baghdasaryan A, Claudel T, Kosters A, Gumhold J, Silbert D, Thüringer A, Leski K, Fickert P, Karpen SJ, Trauner M. Curcumin improves sclerosing cholangitis in Mdr2-/- mice by inhibition of cholangiocyte inflammatory response and portal myofibroblast proliferation. Gut 2010;59:521-30. [PMID: 20332524 DOI: 10.1136/gut.2009.186528] [Cited by in Crossref: 53] [Cited by in F6Publishing: 50] [Article Influence: 4.4] [Reference Citation Analysis]
10 Invernizzi P. Geoepidemiology of autoimmune liver diseases. J Autoimmun. 2010;34:J300-J306. [PMID: 20036105 DOI: 10.1016/j.jaut.2009.12.002] [Cited by in Crossref: 66] [Cited by in F6Publishing: 62] [Article Influence: 5.1] [Reference Citation Analysis]
11 Matsubayashi H, Igarashi K, Kishida Y, Yoshida Y, Sasaki K, Ono H. Sclerosing cholangitis with thumbprint appearance and incomplete steroid response: Suspected IgG4-related PSC. Journal of Digestive Diseases 2014;15:578-82. [DOI: 10.1111/1751-2980.12176] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
12 Bozward AG, Ronca V, Osei-Bordom D, Oo YH. Gut-Liver Immune Traffic: Deciphering Immune-Pathogenesis to Underpin Translational Therapy. Front Immunol 2021;12:711217. [PMID: 34512631 DOI: 10.3389/fimmu.2021.711217] [Reference Citation Analysis]
13 Perri V, Familiari P, Tringali A, Boskoski I, Costamagna G. Plastic biliary stents for benign biliary diseases. Gastrointest Endosc Clin N Am. 2011;21:405-33, viii. [PMID: 21684462 DOI: 10.1016/j.giec.2011.04.012] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 2.5] [Reference Citation Analysis]
14 Nguyen K, D’mello C, Le T, Urbanski S, Swain MG. Regulatory T cells suppress sickness behaviour development without altering liver injury in cholestatic mice. Journal of Hepatology 2012;56:626-31. [DOI: 10.1016/j.jhep.2011.09.014] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
15 Knight C, Murray KF. Hepatobiliary associations with inflammatory bowel disease. Expert Rev Gastroenterol Hepatol. 2009;3:681-691. [PMID: 19929587 DOI: 10.1586/egh.09.53] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
16 Sclair SN, Little E, Levy C. Current Concepts in Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis. Clin Transl Gastroenterol 2015;6:e109. [PMID: 26312413 DOI: 10.1038/ctg.2015.33] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
17 Tsuchikawa T, Kondo S, Hirano S, Tanaka E, Kato K, Matsumoto J, Kubota KC, Shichinohe T. Extensively spreading intraepithelial bile duct carcinoma causing multiple bile duct strictures: report of three cases. Surg Today 2011;41:1674-9. [PMID: 21969205 DOI: 10.1007/s00595-011-4508-0] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
18 Fickert P, Thueringer A, Moustafa T, Silbert D, Gumhold J, Tsybrovskyy O, Lebofsky M, Jaeschke H, Denk H, Trauner M. The role of osteopontin and tumor necrosis factor alpha receptor-1 in xenobiotic-induced cholangitis and biliary fibrosis in mice. Lab Invest. 2010;90:844-852. [PMID: 20368698 DOI: 10.1038/labinvest.2010.61] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 2.3] [Reference Citation Analysis]
19 Gauss A, Sauer P, Stiehl A, Rupp C, Krisam J, Leopold Y, Kloeters-Plachky P, Stremmel W, Gotthardt D. Evaluation of Biliary Calprotectin as a Biomarker in Primary Sclerosing Cholangitis. Medicine (Baltimore) 2016;95:e3510. [PMID: 27124059 DOI: 10.1097/MD.0000000000003510] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
20 Silveira MG, Torok NJ, Gossard AA, Keach JC, Jorgensen RA, Petz JL, Lindor KD. Minocycline in the treatment of patients with primary sclerosing cholangitis: results of a pilot study. Am J Gastroenterol. 2009;104:83-88. [PMID: 19098854 DOI: 10.1038/ajg.2008.14] [Cited by in Crossref: 82] [Cited by in F6Publishing: 63] [Article Influence: 6.3] [Reference Citation Analysis]
21 Kremer AE, Rust C, Eichhorn P, Beuers U, Holdenrieder S. Immune-mediated liver diseases: programmed cell death ligands and circulating apoptotic markers. Expert Rev Mol Diagn 2009;9:139-56. [PMID: 19298138 DOI: 10.1586/14737159.9.2.139] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
22 Sinakos E, Marschall HU, Kowdley KV, Befeler A, Keach J, Lindor K. Bile acid changes after high-dose ursodeoxycholic acid treatment in primary sclerosing cholangitis: Relation to disease progression. Hepatology. 2010;52:197-203. [PMID: 20564380 DOI: 10.1002/hep.23631] [Cited by in Crossref: 76] [Cited by in F6Publishing: 65] [Article Influence: 6.3] [Reference Citation Analysis]
23 Giljaca V, Poropat G, Stimac D, Gluud C. Glucocorticosteroids for primary sclerosing cholangitis. Cochrane Database Syst Rev 2010;:CD004036. [PMID: 20091555 DOI: 10.1002/14651858.CD004036.pub3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
24 Masuoka HC, Vuppalanchi R, Deppe R, Bybee P, Comerford M, Liangpunsakul S, Ghabril M, Chalasani N. Individuals with Primary Sclerosing Cholangitis Have Elevated Levels of Biomarkers for Apoptosis but Not Necrosis. Dig Dis Sci 2015;60:3642-6. [PMID: 26195313 DOI: 10.1007/s10620-015-3805-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
25 Yimam KK, Bowlus CL. Diagnosis and classification of primary sclerosing cholangitis. Autoimmun Rev. 2014;13:445-450. [PMID: 24424180 DOI: 10.1016/j.autrev.2014.01.040] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 4.5] [Reference Citation Analysis]
26 Philips CA, Augustine P, Phadke N. Healthy Donor Fecal Microbiota Transplantation for Recurrent Bacterial Cholangitis in Primary Sclerosing Cholangitis - A Single Case Report. J Clin Transl Hepatol 2018;6:438-41. [PMID: 30637223 DOI: 10.14218/JCTH.2018.00033] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
27 Leung KK, Deeb M, Fischer SE, Gulamhusein A. Recurrent Primary Sclerosing Cholangitis: Current Understanding, Management, and Future Directions. Semin Liver Dis 2021;41:409-20. [PMID: 34182588 DOI: 10.1055/s-0041-1730950] [Reference Citation Analysis]
28 Van Steenbergen W, Braeye L, Harlet R, Nevens F, Fevery J, Desmet V, Roskams T, Pirenne J. Primary sclerosing cholangitis complicated by amyloid A amyloidosis: complete regression of the nephrotic syndrome by liver transplantation. European Journal of Gastroenterology & Hepatology 2010;22:1265-70. [DOI: 10.1097/meg.0b013e32833dbd81] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]